InvestorsHub Logo
Followers 20
Posts 5331
Boards Moderated 0
Alias Born 01/04/2012

Re: None

Sunday, 04/22/2018 7:57:22 AM

Sunday, April 22, 2018 7:57:22 AM

Post# of 14871
Robert Dudley's patent applications for Method of increasing testosterone and related steroid concentrations in women were being prosecuted up until ATRS got the patent for using testosterone to treat HSDD.

Refer to patent applications:
10/153,468
10/925,421


BPAX patents related to reducing CV events and the risk of CV events were published in January 2012 and on February 7, 2012, The patent office received a request to change the Power of Attorney for these applications to Abbott Lab's lawyers. I believe the Non-disclosure agreement was formalized around this time.

Interestingly both a/n patent applications include as parent in part or a division of patent application # 09/651,777 (Patent #6,503,894). A review of the 34 Child Data entries related to this patent application only one stands out as Pending.

13/648,694 filed on 10-10-2012 which is Pending claims the benefit of 09/651,777



Filed 6 days after BPAX and ANIP announced the proposed merger on October 4, 2012. Is it related? I don't know, but given the fact Dr Snabes is with AbbVie, it may very well be.




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News